Tri-GalNAc-DBCO NEW
Price | $499 |
Package | 1mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-18 |
Product Details
Product Name: Tri-GalNAc-DBCO | Purity: 99.92% |
Supply Ability: 10g | Release date: 2024/11/18 |
Product Introduction
Bioactivity
Name | Tri-GalNAc-DBCO |
Description | Tri-GalNAc-DBCO is a PIP-GalNAc coupling compound that binds ASGPR to drive protein down-regulation and target compounds for protein degradation via copper-free strain-promoted azide-alkyne cycloaddition coupled to azide on a non-specifically labeled antibody. |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 80 mg/mL (46.22 mM), Sonication is recommended. |
Inhibitors Related | ARV-393 HCl | Gefitinib-based PROTAC 3 | ACBI1 | ARV-471 | dBET6 | dBET1 | ARV-825 | β-NF-JQ1 | C004019 | GMB-475 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$1960.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$0.00/1G |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2023-02-16 | |
$0.00/25mg |
VIP1Y
|
Xian confluore Biological Technology Co., Ltd.
|
2024-03-20 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY